163 related articles for article (PubMed ID: 20731653)
1. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis.
Teraki Y; Tanaka S; Hitomi K; Izaki S
Br J Dermatol; 2010 Dec; 163(6):1347-51. PubMed ID: 20731653
[No Abstract] [Full Text] [Related]
2. Psoriasiform and pustular eruption induced by etanercept and infliximab.
Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
[No Abstract] [Full Text] [Related]
3. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
4. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
5. The appearance of pustular psoriasis during antitumor necrosis factor therapy.
Goncalves DP; Laurindo I; Scheinberg MA
J Clin Rheumatol; 2006 Oct; 12(5):262. PubMed ID: 17023816
[No Abstract] [Full Text] [Related]
6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
7. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
[TBL] [Abstract][Full Text] [Related]
9. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
10. "Paradoxical" adverse effects caused by anti-tumor necrosis factor-α biological drugs: appearance of psoriasis in a patient treated with infliximab for rheumatoid arthritis.
Satriano RA; Abbate G; Esposito S; Cassaglia B; Piccolo V; Baroni A
Indian J Dermatol Venereol Leprol; 2011; 77(4):536. PubMed ID: 21727719
[No Abstract] [Full Text] [Related]
11. Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.
Pirard D; Arco D; Debrouckere V; Heenen M
Dermatology; 2006; 213(3):182-6. PubMed ID: 17033165
[TBL] [Abstract][Full Text] [Related]
12. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
Aeberli D; Seitz M; Jüni P; Villiger PM
Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
[TBL] [Abstract][Full Text] [Related]
13. Psoriasiform eruption associated with alopecia areata during infliximab therapy.
Nakagomi D; Harada K; Yagasaki A; Kawamura T; Shibagaki N; Shimada S
Clin Exp Dermatol; 2009 Dec; 34(8):923-4. PubMed ID: 19438542
[No Abstract] [Full Text] [Related]
14. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
15. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
16. Onset of psoriasis induced by infliximab.
Bal A; Gurcay E; Aydog E; Umay E; Tatlican S; Cakci A
J Clin Rheumatol; 2008 Apr; 14(2):128-9; author reply 130. PubMed ID: 18391690
[No Abstract] [Full Text] [Related]
17. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?
Michaëlsson G; Kajermo U; Michaëlsson A; Hagforsen E
Br J Dermatol; 2005 Dec; 153(6):1243-4. PubMed ID: 16307676
[No Abstract] [Full Text] [Related]
18. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.
Grinblat B; Scheinberg M
Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
Richette P; Viguier M; Bachelez H; Bardin T
J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
